Press release: ‘balance’ partners with Cognitant information prescription service, 'Healthinote'

The world-renowned menopause app, balance, has partnered with healthcare technology company Cognitant Group, and its health information prescription service, Healthinote, to provide women with extensive information and support when trying to make informed decisions about their menopause treatment.

Founded by leading menopause specialist Dr Louise Newson, the free balance menopause app has been designed to put the power into women’s hands by allowing them to go to their doctor armed with the right knowledge.  By using its bespoke symptom tracker, users can download a personalised health report to take to their healthcare appointment and share their journey within the community – a safe space for discussion and support.

Healthinote is a platform that collects evidence-based health information which doctors, nurses and pharmacists can share with their patients via a digital health information prescription. The platform, which is integrated with over 3,000 GP practices in the UK, is a curated library of trusted health information from a range of providers such as the NHS, esteemed charities, and now balance. Personalised information prescriptions can be prepared in the Healthinote platform, along with some wording to accompany the information prescription link that is sent to the patient.

This partnership will further enhance the user’s knowledge and support. Healthinote will be able to signpost medical professionals towards balance’s up-to-date content and evidence-based information that they can then pass onto their patients for support. With balance’s extensive research, and Healthinote’s aim to share the right information with patients via health care professionals, this relationship will help thousands of women in finding the most suitable information about symptoms and treatments.

balance app is already well embedded into the patient’s treatment pathway being the only menopause app certified by ORCHA and recognised as safe, accredited, compliant, and trusted to feature in digital health libraries for the NHS and other national health bodies around the world.

Dr Louise Newson continues to be at the forefront of menopause research and awareness and founded the app with a single mission in mind, to make menopause support inclusivity and be accessible to all. balance is taking the necessary steps forward in breaking boundaries and rebranding the conversation of menopause whilst supporting all women around the world.

Gaele Lalahy, COO of balance said:

“We are excited to be working with Healthinote and embrace innovative digital health platforms as a conduit to continue our mission to empowered women to make informed decisions about their health during the perimenopause and menopause. This partnership will help thousands of women access evidence-based information via digital prescriptions from their healthcare professional in a new brand-new way. We will continue to be at the forefront of new and ground-breaking research & digital innovations around menopause and continue to share our knowledge to encourage conversation and support.”

Dr. Juhi Tandon, Medical Director of Cognitant, providers of the Healthinote platform, said:

“As a GP with a specialist interest in women’s health, I am delighted to welcome the balance app to the Healthinote library which will really help augment our consultations around menopause and the peri-menopause. Doctors often struggle to impart all the information women need to make an informed decision about menopause / perimenopause management in their time-pressured consultation.  So, being able to efficiently prescribe reliable, trusted and up-to-date education about women’s health issues will benefit both the patient and clinician journey. Providing the right information at the right time and in the right format will empower women to make the right decision for them. I look forward to prescribing the balance app with any patient concerned about perimenopause / menopause going forwards.”

ENDS

You can view this press release in Health Tech World here.